HTA Council Recommendation (as of 26 February 2025) The HTA Council recommends qualitative Fecal immunohistochemical test (FIT) as an annual screening test for colorectal cancer (CRC) for apparently healthy adults aged 50 years and above for financing of DOH and/or PhilHealth (See below for more details). Relevant Information Evidence and Relevant Documents Assessment History Back continue reading : Fecal immunohistochemical test (FIT) as screening tool for colorectal cancer (CRC) among asymptomatic healthy adults, aged 45 years old and above
High-Risk Human Papilloma Virus (HrHPV) Testing (DNA Test) for early detection of cervical cancer
HTA Council Recommendation (as of 13 March 2025) The HTA Council positively recommends High Risk Human Papillomavirus (HrHPV) DNA Test for financing of the Department of Health (DOH) and/or PhilHealth. HRHPV DNA test is recommended for cervical cancer screening in women ages 30 – 65 years, every 5 years as long as the test adheres continue reading : High-Risk Human Papilloma Virus (HrHPV) Testing (DNA Test) for early detection of cervical cancer
Use of Self-Administered Antigen Testing for COVID-19
Date of publication: 07 April 2022 Signed by the Secretary of Health: 28 June 2022 Objectives: HTA Council Recommendation: Evidence Summary:
Rapid Antigen Test Kits for the Diagnosis of COVID-19 (September 2021 Updates)
Date of publication: September 27, 2021 Objectives: Evidence Summary: Use of Rapid Antigen Test Kits for the Diagnosis of COVID-19 HTAC Recommendation Review:
Use of RT-PCR Testing for COVID-19 (April 2021 Assessment)
Date of publication: April 30, 2021 Objectives: Evidence Summary: Use of RT-PCR Testing for COVID-19 HTAC Recommendation Review: